Global mRNA Vaccines & Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Published On: August 2018
 
Report ID:285000
 
 
Pages: 135




mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.

Scope of the Report:

This report focuses on the mRNA Vaccines & Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

mRNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of mRNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.

Since the product still in development stage, so companies rely mainly on investment or cooperation to obtain funding to continue research and development.

The research of mRNA Vaccines & Therapeutics to treat infectious disease, cancer and others. The expenses on infectious disease is the most, with the market share of 46% in 2017.

The worldwide market for mRNA Vaccines & Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Moderna Therapeutics

CureVac

Translate Bio

BioNTech

Sangamo Therapeutics

Argos Therapeutics

In-Cell-Art

eTheRNA

Ethris

Tiba Biotechnology

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Standardization Of Cancer Treatment MRNA Vaccine

Individualized Cancer Treatment MRNA Vaccine

Infectious Disease Treatment MRNA Vaccine

Infection Prevention MRNA Vaccine

Market Segment by Applications, can be divided into

Infectious Disease

Cancer

Other

There are 15 Chapters to deeply display the global mRNA Vaccines & Therapeutics market.

Chapter 1, to describe mRNA Vaccines & Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of mRNA Vaccines & Therapeutics, with sales, revenue, and price of mRNA Vaccines & Therapeutics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of mRNA Vaccines & Therapeutics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, mRNA Vaccines & Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe mRNA Vaccines & Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview

1.1 mRNA Vaccines & Therapeutics Introduction

1.2 Market Analysis by Type

1.2.1 Standardization Of Cancer Treatment MRNA Vaccine

1.2.2 Individualized Cancer Treatment MRNA Vaccine

1.2.3 Infectious Disease Treatment MRNA Vaccine

1.2.4 Infection Prevention MRNA Vaccine

1.3 Market Analysis by Applications

1.3.1 Infectious Disease

1.3.2 Cancer

1.3.3 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Moderna Therapeutics

2.1.1 Business Overview

2.1.2 mRNA Vaccines & Therapeutics Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 CureVac

2.2.1 Business Overview

2.2.2 mRNA Vaccines & Therapeutics Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Translate Bio

2.3.1 Business Overview

2.3.2 mRNA Vaccines & Therapeutics Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 BioNTech

2.4.1 Business Overview

2.4.2 mRNA Vaccines & Therapeutics Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Sangamo Therapeutics

2.5.1 Business Overview

2.5.2 mRNA Vaccines & Therapeutics Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Argos Therapeutics

2.6.1 Business Overview

2.6.2 mRNA Vaccines & Therapeutics Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 In-Cell-Art

2.7.1 Business Overview

2.7.2 mRNA Vaccines & Therapeutics Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 eTheRNA

2.8.1 Business Overview

2.8.2 mRNA Vaccines & Therapeutics Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Ethris

2.9.1 Business Overview

2.9.2 mRNA Vaccines & Therapeutics Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Tiba Biotechnology

2.10.1 Business Overview

2.10.2 mRNA Vaccines & Therapeutics Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global mRNA Vaccines & Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Manufacturer (2016-2017)

3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2017

3.3.2 Top 6 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global mRNA Vaccines & Therapeutics Market Analysis by Regions

4.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Regions

4.1.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Regions (2013-2018)

4.1.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Regions (2013-2018)

4.2 North America mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

4.3 Europe mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

4.5 South America mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

5 North America mRNA Vaccines & Therapeutics by Countries

5.1 North America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries

5.1.1 North America mRNA Vaccines & Therapeutics Sales and Market Share by Countries (2013-2018)

5.1.2 North America mRNA Vaccines & Therapeutics Revenue and Market Share by Countries (2013-2018)

5.2 United States mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

5.3 Canada mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

5.4 Mexico mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

6 Europe mRNA Vaccines & Therapeutics by Countries

6.1 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries

6.1.1 Europe mRNA Vaccines & Therapeutics Sales and Market Share by Countries (2013-2018)

6.1.2 Europe mRNA Vaccines & Therapeutics Revenue and Market Share by Countries (2013-2018)

6.2 Germany mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

6.3 UK mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

6.4 France mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

6.5 Russia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

6.6 Italy mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

7 Asia-Pacific mRNA Vaccines & Therapeutics by Countries

7.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Market Share by Countries (2013-2018)

7.2 China mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

7.3 Japan mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

7.4 Korea mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

7.5 India mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

7.6 Southeast Asia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

8 South America mRNA Vaccines & Therapeutics by Countries

8.1 South America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries

8.1.1 South America mRNA Vaccines & Therapeutics Sales and Market Share by Countries (2013-2018)

8.1.2 South America mRNA Vaccines & Therapeutics Revenue and Market Share by Countries (2013-2018)

8.2 Brazil mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

8.3 Argentina mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

8.4 Colombia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

9 Middle East and Africa mRNA Vaccines & Therapeutics by Countries

9.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

9.3 UAE mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

9.4 Egypt mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

9.5 Nigeria mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

9.6 South Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2013-2018)

10 Global mRNA Vaccines & Therapeutics Market Segment by Type

10.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Type (2013-2018)

10.1.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2013-2018)

10.2 Standardization Of Cancer Treatment MRNA Vaccine Sales Growth and Price

10.2.1 Global Standardization Of Cancer Treatment MRNA Vaccine Sales Growth (2013-2018)

10.2.2 Global Standardization Of Cancer Treatment MRNA Vaccine Price (2013-2018)

10.3 Individualized Cancer Treatment MRNA Vaccine Sales Growth and Price

10.3.1 Global Individualized Cancer Treatment MRNA Vaccine Sales Growth (2013-2018)

10.3.2 Global Individualized Cancer Treatment MRNA Vaccine Price (2013-2018)

10.4 Infectious Disease Treatment MRNA Vaccine Sales Growth and Price

10.4.1 Global Infectious Disease Treatment MRNA Vaccine Sales Growth (2013-2018)

10.4.2 Global Infectious Disease Treatment MRNA Vaccine Price (2013-2018)

10.5 Infection Prevention MRNA Vaccine Sales Growth and Price

10.5.1 Global Infection Prevention MRNA Vaccine Sales Growth (2013-2018)

10.5.2 Global Infection Prevention MRNA Vaccine Price (2013-2018)

11 Global mRNA Vaccines & Therapeutics Market Segment by Application

11.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2013-2018)

11.2 Infectious Disease Sales Growth (2013-2018)

11.3 Cancer Sales Growth (2013-2018)

11.4 Other Sales Growth (2013-2018)

12 mRNA Vaccines & Therapeutics Market Forecast (2018-2023)

12.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2018-2023)

12.2 mRNA Vaccines & Therapeutics Market Forecast by Regions (2018-2023)

12.2.1 North America mRNA Vaccines & Therapeutics Market Forecast (2018-2023)

12.2.2 Europe mRNA Vaccines & Therapeutics Market Forecast (2018-2023)

12.2.3 Asia-Pacific mRNA Vaccines & Therapeutics Market Forecast (2018-2023)

12.2.4 South America mRNA Vaccines & Therapeutics Market Forecast (2018-2023)

12.2.5 Middle East and Africa mRNA Vaccines & Therapeutics Market Forecast (2018-2023)

12.3 mRNA Vaccines & Therapeutics Market Forecast by Type (2018-2023)

12.3.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2018-2023)

12.3.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Type (2018-2023)

12.4 mRNA Vaccines & Therapeutics Market Forecast by Application (2018-2023)

12.4.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2018-2023)

12.4.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source




Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \


Copyright © 2019 Fior Market Research LLP, All Rights Reserved.